RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+23.63%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$1.11B
AUM Growth
+$1.11B
(+21%)
Cap. Flow
+$85.8M
Cap. Flow
% of AUM
7.7%
Top 10 Holdings %
Top 10 Hldgs %
48.19%
Holding
72
New
18
Increased
12
Reduced
16
Closed
18
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
$53.2M |
| 2 |
ENDP
Endo International plc
ENDP
|
$50.3M |
| 3 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
$41.9M |
| 4 |
ALR
Alere Inc
ALR
|
$32.5M |
| 5 |
Biogen
BIIB
|
$23.1M |
Top Sells
| 1 |
RAD
Rite Aid Corporation
RAD
|
$45.4M |
| 2 |
CELG
Celgene Corp
CELG
|
$38.3M |
| 3 |
Gilead Sciences
GILD
|
$34.7M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$25.3M |
| 5 |
AstraZeneca
AZN
|
$18.2M |
Sector Composition
| 1 | Healthcare | 81.12% |
| 2 | Financials | 2.03% |
| 3 | Technology | 1.63% |
| 4 | Communication Services | 1.57% |
| 5 | Consumer Staples | 1.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WOOF
26
DELISTED
VCA Inc.
WOOF
| $16.9M | 1.52% | +307,804 | New | +$16.9M |
|
|
TRIV
27
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
| $16.7M | 1.5% | 1,588,623 -166,945 | -10% | -$1.75M |
|
28
ProQR Therapeutics
PRQR
$237M
| $16.4M | 1.48% | 751,171 | – | – |
|
|
HNT
29
DELISTED
HEALTH NET INC
HNT
| $16.4M | 1.47% | 270,358 -38,687 | -13% | -$2.34M |
|
|
ITCI
30
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $16M | 1.43% | 668,671 -322,139 | -33% | -$7.69M |
|
31
Globus Medical
GMED
$8.27B
| $15.4M | 1.39% | 611,731 | – | – |
|
32
Celldex Therapeutics
CLDX
$1.47B
| $15.2M | 1.37% | 547,000 +520,900 | +1,996% | +$14.5M |
|
33
Accuray
ARAY
$157M
| $14.1M | 1.27% | 1,515,475 -20,000 | -1% | -$186K |
|
34
Arbutus Biopharma
ABUS
$711M
| $12.2M | 1.1% | +700,000 | New | +$12.2M |
|
|
KYTH
35
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $11.3M | 1.01% | +225,062 | New | +$11.3M |
|
36
Atara Biotherapeutics
ATRA
$84.6M
| $11M | 0.99% | 265,205 +939 | +0.4% | +$39K |
|
|
NSTG
37
DELISTED
NanoString Technologies, Inc.
NSTG
| $11M | 0.99% | 1,077,642 -188,896 | -15% | -$1.92M |
|
|
NVTA
38
DELISTED
Invitae Corporation
NVTA
| $10.9M | 0.98% | +785,131 | New | +$10.9M |
|
|
GWPH
39
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $10.9M | 0.97% | +119,114 | New | +$10.9M |
|
|
GNCA
40
DELISTED
Genocea Biosciences, Inc.
GNCA
| $9.45M | 0.85% | +796,900 | New | +$9.45M |
|
|
BLCM
41
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $9.28M | 0.83% | 445,221 -415,588 | -48% | -$8.67M |
|
|
NUVA
42
DELISTED
NuVasive, Inc.
NUVA
| $8.51M | 0.76% | 185,137 -173,542 | -48% | -$7.98M |
|
43
Cerus
CERS
$251M
| $6.87M | 0.62% | +1,647,727 | New | +$6.87M |
|
44
Option Care Health
OPCH
$4.65B
| $6.11M | 0.55% | +1,378,200 | New | +$6.11M |
|
|
FLXN
45
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $4.27M | 0.38% | 189,624 -125,520 | -40% | -$2.83M |
|
|
AKAO
46
DELISTED
Achaogen, Inc.
AKAO
| $3.89M | 0.35% | 398,340 -335,613 | -46% | -$3.28M |
|
|
OTIC
47
DELISTED
Otonomy, Inc.
OTIC
| $2.79M | 0.25% | +78,972 | New | +$2.79M |
|
48
Carisma Therapeutics
CARM
$8.98M
| $2.14M | 0.19% | 240,000 | – | – |
|
49
iShares US Healthcare Providers ETF
IHF
$793M
| $1.14M | 0.1% | 8,599 +6,099 | +244% | +$811K |
|
50
VanEck Pharmaceutical ETF
PPH
$621M
| $457K | 0.04% | 6,500 | – | – |
|